Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

CRWE.OB ANX, TGN, CFFI - Stock Updates! from



Crown Equity Holdings, Inc. recently announced its joint venture with Communication Expert Corporation.

The cornerstone of Crown Tele Services Inc. strategy is to meet the highest standards when it comes to delivering VoIP (Voice over Internet Protocol) communications solutions specifically designed to meet the business and residential market needs.

“We are excited to be partnering with Communication Expert Corporation,” said Kenneth Bosket, President of CRWE “As part of this joint venture we look forward to building an outstanding team to develop and deliver voice and video VoIP services globally.”

According to ABI Research, the latest global business VoIP services forecasts show that the value of the overall market, which includes VoIP integrated access, SIP trunking, hosted IP-PBX/IP Centrex and managed IP-PBX services, is set to double over the next five years, to exceed $20 billion by 2015.

To learn more about CRWE visit:


ADVENTRX Pharmaceuticals, Inc. (NYSE Amex:ANX) recently reported financial results for the three and nine months ended September 30, 2010.

ADVENTRX's net loss applicable to common stock for the third quarter of 2010 was $1.8 million, or $0.13 per share, compared to net loss applicable to common stock of $2.7 million, or $0.57 per share, for the same period in 2009. Net loss applicable to common stock and net loss were the same for the three months ended September 30, 2010. Net loss applicable to common stock for the three months ended September 30, 2009 included a non-cash, deemed dividend expense of $0.4 million related to the Company's July and August 2009 equity financings.

ADVENTRX Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on in-licensing, developing, and commercializing proprietary product candidates for the treatment of cancer.


Tengion, Inc. (Nasdaq:TNGN) provided a business update and recently reported its financial results for the third quarter ended September 30, 2010.

For the third quarter ended September 30, 2010, the Company reported an adjusted net loss of $6.7 million or $0.54 per basic and diluted common share, compared with an adjusted net loss of $7.2 million, or $1.14 per basic and diluted common share, for the same period in 2009. The decreased adjusted net loss for the 2010 period was primarily due to a $0.4 million decrease in interest expense resulting from lower average debt balances during the 2010 period. The loss per basic and diluted common share for the quarter ended September 30, 2010 was significantly affected by the Company's initial public offering of 6,000,000 shares in April 2010.

Operating expenses during the quarter ended September 30, 2010, decreased to $6.3 million from $6.4 million during the quarter ended September 30, 2009, primarily due to a decrease in compensation and related expenses of $0.4 million, which was offset in part by an increase of $0.3 million in external preclinical study expenses associated with the Neo-Kidney Augment program.

Tengion, Inc., a regenerative medicine company, focuses on discovering, developing, manufacturing, and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues to address unmet medical needs in urologic, renal, gastrointestinal and vascular diseases.


C&F Financial Corporation (Nasdaq:CFFI), the one-bank holding company for C&F Bank, recently reported net income of $2.59 million for the third quarter of 2010, compared with $1.66 million for the third quarter of 2009.

C&F Financial Corporation operates as the holding company for Citizens and Farmers Bank that provides various banking and related financial services. It offers retail banking, mortgage banking, and consumer finance services to individuals and businesses. The company?s deposit products include demand deposits; checking, savings, and money market accounts; time deposits; and certificates of deposit.


Signup for FREE Daily Stock Alerts From


Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.